Neuroimaging of Inflammation in Memory and Related Other Disorders (NIMROD) study protocol: a deep phenotyping cohort study of the role of brain inflammation in dementia, depression and other neurological illnesses
暂无分享,去创建一个
Luca Passamonti | Guy B. Williams | Young T. Hong | Elijah Mak | Li Su | James B Rowe | Guy Williams | Tim D Fryer | Ajenthan Surendranathan | Young T Hong | Jonathan P Coles | J. O'Brien | J. Rowe | L. Passamonti | T. Fryer | J. Coles | R. Arnold | F. Aigbirhio | L. Su | P. V. Rodríguez | W. R. Bevan-Jones | Patricia Vázquez Rodríguez | E. Mak | A. Surendranathan | Robert Arnold | Patricia Vázquez Rodríguez | W Richard Bevan-Jones | John T O'Brien | Franklin Aigbirhio | Patricia Vázquez Rodríguez | Brien | O. JohnT. | John T O ’ Brien | Dr W Richard Bevan-Jones
[1] T. Robbins,et al. Early Detection and Differential Diagnosis of Alzheimer’s Disease and Depression with Neuropsychological Tasks , 2001, Dementia and Geriatric Cognitive Disorders.
[2] J. Trojanowski,et al. TDP-43 proteinopathy: the neuropathology underlying major forms of sporadic and familial frontotemporal lobar degeneration and motor neuron disease , 2007, Acta Neuropathologica.
[3] Daniel R. Schonhaut,et al. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease. , 2016, Brain : a journal of neurology.
[4] A. Hammers,et al. Diagnostic accuracy of (18)F amyloid PET tracers for the diagnosis of Alzheimer's disease , 2016 .
[5] W. Klunk,et al. [F‐18]AV‐1451 positron emission tomography retention in choroid plexus: More than “off‐target” binding , 2016, Annals of neurology.
[6] John R Hodges,et al. The Addenbrooke's Cognitive Examination Revised (ACE‐R): a brief cognitive test battery for dementia screening , 2006, International journal of geriatric psychiatry.
[7] Min-Ying Su,et al. Early clinical PET imaging results with the novel PHF-tau radioligand [F18]-T808. , 2014, Journal of Alzheimer's disease : JAD.
[8] Nick C Fox,et al. The Diagnosis of Mild Cognitive Impairment due to Alzheimer’s Disease: Recommendations from the National Institute on Aging-Alzheimer’s Association Workgroups on Diagnostic Guidelines for Alzheimer’s Disease , 2011 .
[9] Clifford R. Jack,et al. An autoradiographic evaluation of AV-1451 Tau PET in dementia , 2016, Acta Neuropathologica Communications.
[10] M G Spillantini,et al. Alpha-synuclein in Lewy bodies. , 1997, Nature.
[11] R. Maccioni,et al. Neuroinflammation in the pathogenesis of Alzheimer’s disease. A rational framework for the search of novel therapeutic approaches , 2014, Front. Cell. Neurosci..
[12] Paul Edison,et al. Microglia, Amyloid, and Glucose Metabolism in Parkinson’s Disease with and without Dementia , 2013, Neuropsychopharmacology.
[13] Nick C Fox,et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. , 2011, Brain : a journal of neurology.
[14] P. Suñé,et al. Positive Outcomes Influence the Rate and Time to Publication, but Not the Impact Factor of Publications of Clinical Trial Results , 2013, PloS one.
[15] O. Garaschuk,et al. Neuroinflammation in Alzheimer's disease , 2015, The Lancet Neurology.
[16] H. Arai,et al. Synthesis and preliminary evaluation of 2-arylhydroxyquinoline derivatives for tau imaging. , 2014, Journal of labelled compounds & radiopharmaceuticals.
[17] Alexander Gerhard,et al. In vivo imaging of microglial activation with [11C](R)‐PK11195 PET in corticobasal degeneration , 2004, Movement disorders : official journal of the Movement Disorder Society.
[18] D. Wilcock,et al. Neuroinflammation in Alzheimer’s disease; A source of heterogeneity and target for personalized therapy , 2015, Neuroscience.
[19] E. Tolosa,et al. Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force , 2007, Movement disorders : official journal of the Movement Disorder Society.
[20] R. Barker,et al. The utility of the Cambridge Behavioural Inventory in neurodegenerative disease , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.
[21] Klaus P. Ebmeier,et al. Innate and adaptive immunity in the development of depression: An update on current knowledge and technological advances , 2016, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[22] Ronald Boellaard,et al. Optimization of supervised cluster analysis for extracting reference tissue input curves in (R)-[11C]PK11195 brain PET studies , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[23] M. Onofrj,et al. Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium , 2006, Neurology.
[24] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[25] C. Plata-salamán,et al. Inflammation and Alzheimer’s disease , 2000, Neurobiology of Aging.
[26] Olivier Colliot,et al. Early and protective microglial activation in Alzheimer's disease: a prospective study using 18F-DPA-714 PET imaging. , 2016, Brain : a journal of neurology.
[27] J. O'Brien,et al. Imaging of neuroinflammation in dementia: a review , 2015, Journal of Neurology, Neurosurgery & Psychiatry.
[28] O. Hansson,et al. 18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers , 2016, Brain : a journal of neurology.
[29] U. Bogdahn,et al. Structural and functional rejuvenation of the aged brain by an approved anti-asthmatic drug , 2015, Nature Communications.
[30] P. Mcgeer,et al. The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy , 2013, Acta Neuropathologica.
[31] D. Brooks. Imaging neuroinflammation in Alzheimer’s and other dementias: recent advances and future directions , 2016, Neurobiology of Aging.
[32] M. Mega,et al. The Neuropsychiatric Inventory , 1994, Neurology.
[33] D. Perani,et al. In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson's disease. , 2013, Parkinsonism & related disorders.
[34] Young T. Hong,et al. [18F]AV‐1451 PET in behavioral variant frontotemporal dementia due to MAPT mutation , 2016, Annals of clinical and translational neurology.
[35] L. Golbe,et al. A clinical rating scale for progressive supranuclear palsy. , 2007, Brain : a journal of neurology.
[36] C. P. Hughes,et al. A New Clinical Scale for the Staging of Dementia , 1982, British Journal of Psychiatry.
[37] B. Miller,et al. Classification of primary progressive aphasia and its variants , 2011, Neurology.
[38] H. Kolb,et al. [18F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease , 2013, Alzheimer's & Dementia.
[39] D. Royall,et al. The FAB: A frontal assessment battery at bedside , 2001, Neurology.
[40] M. Hallett,et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) , 1996, Neurology.
[41] Min-Ying Su,et al. Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807. , 2013, Journal of Alzheimer's disease : JAD.
[42] J. O'Brien,et al. Neuroinflammation in Lewy body dementia. , 2015, Parkinsonism & related disorders.
[43] I G McKeith,et al. The Clinician Assessment of Fluctuation and the One Day Fluctuation Assessment Scale. Two methods to assess fluctuating confusion in dementia. , 2000, The British journal of psychiatry : the journal of mental science.
[44] D. Brooks,et al. Imaging neuroinflammation in Alzheimer's disease and other dementias: Recent advances and future directions , 2015, Alzheimer's & Dementia.
[45] P. Rabbitt,et al. A study of performance on tests from the CANTAB battery sensitive to frontal lobe dysfunction in a large sample of normal volunteers: Implications for theories of executive functioning and cognitive aging , 1998, Journal of the International Neuropsychological Society.
[46] B. Winblad,et al. DEFECTIVE BRAIN MICROTUBULE ASSEMBLY IN ALZHEIMER'S DISEASE , 1986, The Lancet.
[47] S. Ambrosio,et al. Lymphocyte populations in Parkinson’s disease and in rat models of parkinsonism , 2001, Journal of Neuroimmunology.
[48] M. Irwin,et al. From stress to inflammation and major depressive disorder: a social signal transduction theory of depression. , 2014, Psychological bulletin.
[49] D. Praticò,et al. Zileuton Improves Memory Deficits, Amyloid and Tau Pathology in a Mouse Model of Alzheimer’s Disease with Plaques and Tangles , 2013, PloS one.
[50] Bruce R. Rosen,et al. Cortical surface-based analysis reduces bias and variance in kinetic modeling of brain PET data , 2014, NeuroImage.
[51] S. Nam,et al. Inflammation and Alzheimer’s disease , 2010, Archives of pharmacal research.
[52] J. Morris,et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[53] G. Pawelec,et al. Peripheral Immune Signatures in Alzheimer Disease. , 2016, Current Alzheimer research.
[54] Keith A. Johnson,et al. Validating novel tau positron emission tomography tracer [F‐18]‐AV‐1451 (T807) on postmortem brain tissue , 2015, Annals of neurology.
[55] J. Jankovic,et al. Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results , 2008, Movement disorders : official journal of the Movement Disorder Society.
[56] Chandler D. Gatenbee,et al. Cytokine expression and microglial activation in progressive supranuclear palsy. , 2011, Parkinsonism & related disorders.
[57] M. Åsberg,et al. A New Depression Scale Designed to be Sensitive to Change , 1979, British Journal of Psychiatry.
[58] Jing Zhang,et al. Mapping neuroinflammation in frontotemporal dementia with molecular PET imaging , 2015, Journal of Neuroinflammation.
[59] Kosloski,et al. CD4+ Regulatory and Effector/Memory T Cell Subsets Profile Motor Dysfunction in Parkinson’s Disease , 2012, Journal of Neuroimmune Pharmacology.
[60] Pablo López,et al. INECO Frontal Screening (IFS): A brief, sensitive, and specific tool to assess executive functions in dementia–CORRECTED VERSION , 2009, Journal of the International Neuropsychological Society.
[61] A. Joshi,et al. Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages. , 2016, Brain : a journal of neurology.
[62] Martin Knapp,et al. Dementia UK: Update , 2014 .
[63] Dorian B. McGavern,et al. Microglia development and function. , 2014, Annual review of immunology.
[64] J. Trojanowski,et al. Imaging of Tau Pathology in a Tauopathy Mouse Model and in Alzheimer Patients Compared to Normal Controls , 2013, Neuron.
[65] I. Litvan,et al. Unraveling progressive supranuclear palsy: from the bedside back to the bench. , 2007, Parkinsonism & related disorders.